Health Care Inequities Lead To A Mistrust Of Research

OVERCOMPENSATION: Atoning for wrongs led to exclusion of minorities, notes Robert F. Murray, Jr. Minority Americans' mistrust of science, fostered in large part by the notorious Tuskegee study and advanced by inequities in health care, continues today, according to observers. While hard evidence is lacking, many scientists believe that bad feelings make it difficult for them to recruit minorities as participants in biomedical research studies in such areas as cancer and AIDS. Others say that

Written byThomas Durso
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share


OVERCOMPENSATION: Atoning for wrongs led to exclusion of minorities, notes Robert F. Murray, Jr.
Minority Americans' mistrust of science, fostered in large part by the notorious Tuskegee study and advanced by inequities in health care, continues today, according to observers. While hard evidence is lacking, many scientists believe that bad feelings make it difficult for them to recruit minorities as participants in biomedical research studies in such areas as cancer and AIDS.

Others say that while minorities' attitudes are changing, much more examination is needed to pinpoint exactly how they feel about science and research. This concern comes at a time when the National Institutes of Health, via its Revitalization Act of 1993, has ordered the adequate representation of women, minorities, and racial and ethnic subgroups in studies it funds (M.E. Watanabe, The Scientist, March 6, 1995, page 14).

"With the minority community, particularly the African American community, what pops ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies